Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Medtech startup...

    Medtech startup Caredose plans to expand footprint to 5 new cities

    GarimaWritten by Garima Published On 2019-04-06T09:05:12+05:30  |  Updated On 6 April 2019 9:05 AM IST
    Medtech startup Caredose plans to expand footprint to 5 new cities

    Currently, Caredose has a presence in New Delhi and Haryana.


    New Delhi: Medical technology startup Caredose Thursday said it is planning to expand its footprint to five new cities -- Hyderabad, Mumbai, Pune, Chennai and Bengaluru.


    "We will also be looking at global expansion next year. Our target countries include Indonesia, Qatar, the UAE, the UK, Nigeria, and South Africa where we will be focusing on both private and public sectors," Caredose COO Kinshuk Kocher said in a statement.


    Read Also: Medtech zone will help minimize dependency on medical device imports: Andhra CM


    Currently, the company has a presence in New Delhi and Haryana.


    Caredose CEO Gauri Angrish said the company is addressing the issues of medicine non-adherence which are critical to the health and well-being of chronic patients.


    "We decided to choose India for the launch as it has the largest chronic patient pool, given the sheer size of population and incidence of ailments," Angrish said.


    The company has registered healthy growth in January-March 2019 compared to the same period last year, she said.


    Read Also: Swiss medtech firm Implantica plans stock market listing


    She further added that there are more than 1.2 billion non-adherent patients globally and Caredose's intent is to make a substantial dent in the number by facilitating pre-organised and labelled doses with the help of IoT dispenser for auto dispensing and tracking dose adherence in real time.

    ailmentsBengaluruCaredoseCaredose CEOCEOChennaiGauri Angrishglobal expansionhealthHealthcareHealthcare Newshealthcare startupHyderabadIndonesiaKinshuk Kochermedical technologyMedtechMumbaiNew DelhiNigeriaPuneUnited Kingdom
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok